DE3577185D1 - Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. - Google Patents

Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.

Info

Publication number
DE3577185D1
DE3577185D1 DE8585307738T DE3577185T DE3577185D1 DE 3577185 D1 DE3577185 D1 DE 3577185D1 DE 8585307738 T DE8585307738 T DE 8585307738T DE 3577185 T DE3577185 T DE 3577185T DE 3577185 D1 DE3577185 D1 DE 3577185D1
Authority
DE
Germany
Prior art keywords
vivo
production
contrast agents
diagnostic methods
paramagnetic contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585307738T
Other languages
English (en)
Inventor
Trond Jacobsen
Jo Klaveness
Bernt Jabes Lindberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8405501A external-priority patent/SE465909B/sv
Priority claimed from SE8405500A external-priority patent/SE465908B/sv
Application filed by Nycomed AS filed Critical Nycomed AS
Application granted granted Critical
Publication of DE3577185D1 publication Critical patent/DE3577185D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
DE8585307738T 1984-11-01 1985-10-25 Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. Expired - Fee Related DE3577185D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8405501A SE465909B (sv) 1984-11-01 1984-11-01 Partikelformat diagnosticeringsmedel innehaallande en paramagnetisk metall
SE8405500A SE465908B (sv) 1984-11-01 1984-11-01 Diagnosticeringspartiklar innehaallande en paramagnetisk metall

Publications (1)

Publication Number Publication Date
DE3577185D1 true DE3577185D1 (de) 1990-05-23

Family

ID=26658808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585307738T Expired - Fee Related DE3577185D1 (de) 1984-11-01 1985-10-25 Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.

Country Status (6)

Country Link
US (1) US4985233A (de)
EP (1) EP0184899B1 (de)
JP (1) JPH0678246B2 (de)
DE (1) DE3577185D1 (de)
DK (1) DK164486C (de)
NO (1) NO169525C (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
EP0330801A1 (de) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetische, diamagnetische oder paramagnetische Partikel, die in der Diagnose und Behandlung von Krankheiten nützlich sind
US6203777B1 (en) * 1983-12-21 2001-03-20 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using carbohydrate particles
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上（およびスペクトルシフト）のためのポリキレ−ト剤
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5219554A (en) 1986-07-03 1993-06-15 Advanced Magnetics, Inc. Hydrated biodegradable superparamagnetic metal oxides
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US4951675A (en) * 1986-07-03 1990-08-28 Advanced Magnetics, Incorporated Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
FR2612400A1 (fr) * 1987-03-16 1988-09-23 Centre Nat Rech Scient Microcapsules contenant un marqueur radioactif et/ou paramagnetique sous forme de chelate, et leur utilisation dans le domaine de l'imagerie medicale
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5049667A (en) * 1987-04-14 1991-09-17 Guerbet S.A. Nitrogen-containing cyclic ligands
US5154179A (en) * 1987-07-02 1992-10-13 Medical Magnetics, Inc. Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
DE3724188C2 (de) * 1987-07-17 1995-05-18 Heinz Dr Gries Metallhaltige Oligosaccharid-Polysulfate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
US6013531A (en) * 1987-10-26 2000-01-11 Dade International Inc. Method to use fluorescent magnetic polymer particles as markers in an immunoassay
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
EP0381742B1 (de) 1988-08-04 1996-06-19 Advanced Magnetics Incorporated Von einem rezeptor induziertes kontrastmittel für den endocytose-typ mri
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8916780D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5393525A (en) * 1989-07-21 1995-02-28 Nycomed Imaging As Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5358702A (en) * 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging
JPH05506227A (ja) * 1990-04-10 1993-09-16 イマルクス　ファーマシューティカル　コーポレーション 磁気共鳴画像用造影剤としてのポリマー
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5236693A (en) * 1990-11-14 1993-08-17 Brigham And Women's Hospital Medical ultrasound contrast agent and method of using same
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5310539A (en) * 1991-04-15 1994-05-10 Board Of Regents, The University Of Texas System Melanin-based agents for image enhancement
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
ES2103947T5 (es) * 1991-06-03 2001-05-16 Nycomed Imaging As Mejoras introducidas en o relacionadas con agentes de contraste.
DE69223748T2 (de) * 1991-06-11 1998-04-23 Meito Sangyo Kk Oxidierte zusammensetzung, enthaltend ein wasserlösliches carboxypolysaccharid und magnetisches eisenoxid
DE69203080T2 (de) * 1991-06-17 1996-02-01 Dade Int Inc Verfahren zur Herstellung magnetisch empfindlicherPolymerpartikel und ihre Anwendung.
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
JPH07501331A (ja) * 1991-11-19 1995-02-09 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 改良された診断用の造影のためのゲル粒子造影剤
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
JP2911674B2 (ja) * 1992-02-20 1999-06-23 明治乳業株式会社 消化管造影用組成物
KR930019648A (ko) * 1992-03-27 1993-10-18 도키 가츠유키 테트라아자시클로도덴칸 유도체 및 그의 용도
DK0580878T3 (da) * 1992-06-01 1996-02-12 Basf Ag Anvendelse af dispersioner af magneto-ioniske partikler som MRI-kontrastmedier
EP0654973A4 (de) * 1992-07-21 1995-08-09 Gen Hospital Corp Anordnung zur abgabe von medikamenten an das lymphgewebe.
JPH08502300A (ja) * 1992-10-14 1996-03-12 スターリング ウィンスロップ アイエヌシー． 治療および診断像形成組成物および方法
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
EP0664819B1 (de) * 1992-10-14 1997-08-06 Nycomed Imaging As Chelatpolymere
US5401492A (en) * 1992-12-17 1995-03-28 Sterling Winthrop, Inc. Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
EP0683676A4 (de) * 1993-02-02 1998-09-30 Neorx Corp Gelenkte bioverteilung von kleinen molekülen.
US5532006A (en) * 1993-04-23 1996-07-02 The Board Of Trustees Of The University Of Illinois Magnetic gels which change volume in response to voltage changes for MRI
US6122540A (en) * 1994-06-08 2000-09-19 The Regents Of The University Of California Noninvasive measurement of renal hemodynamic functions using magnetic resonance imaging
DE4428851C2 (de) * 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
FR2749082B1 (fr) * 1996-05-24 1998-06-26 Bio Merieux Particules superparamagnetiques et monodispersees
NL1003776C2 (nl) * 1996-08-09 1998-02-20 Cooperatie Cosun U A Milieuvriendelijke complexanten voor zware metalen
WO1998044910A1 (en) 1997-04-09 1998-10-15 Philipp Lang NEW TECHNIQUE TO MONITOR DRUG DELIVERY NONINVASIVELY $i(IN VIVO)
ES2463469T3 (es) * 2000-09-21 2014-05-28 Glasstech, Inc. Molde articulado de formación para hojas de vidrio
US20030100830A1 (en) * 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
US20040143180A1 (en) * 2001-11-27 2004-07-22 Sheng-Ping Zhong Medical devices visible under magnetic resonance imaging
AU2003281270B2 (en) * 2002-07-02 2010-07-22 Universitair Medisch Centrum Utrecht Scanning suspension comprising a particle with a diameter of at least 1 micrometer
WO2004009134A1 (en) * 2002-07-22 2004-01-29 Bracco Imaging S.P.A. Procedures of cellular labelling with paramagnetic complexes for mri applications
US8620406B2 (en) * 2004-01-23 2013-12-31 Boston Scientific Scimed, Inc. Medical devices visible by magnetic resonance imaging
US7761138B2 (en) 2004-03-12 2010-07-20 Boston Scientific Scimed, Inc. MRI and X-ray visualization
US7483732B2 (en) * 2004-04-15 2009-01-27 Boston Scientific Scimed, Inc. Magnetic resonance imaging of a medical device and proximate body tissue
EP1793860B1 (de) * 2004-07-15 2009-08-05 GynaecologIQ B.V. Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
US7778684B2 (en) * 2005-08-08 2010-08-17 Boston Scientific Scimed, Inc. MRI resonator system with stent implant
US20070239256A1 (en) * 2006-03-22 2007-10-11 Jan Weber Medical devices having electrical circuits with multilayer regions
US10996218B2 (en) 2008-03-11 2021-05-04 Ournextbaby Llc Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.
WO2012036691A1 (en) 2010-09-16 2012-03-22 Urobiologics Llc Use of female mammal's urine for determination of fetal gender related characteristics

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862920A (en) * 1956-06-07 1958-12-02 Ohio Commw Eng Co Ferrous carboxymethyl dextran
GB1175834A (en) * 1966-04-07 1969-12-23 Atomic Energy Authority Uk Improvements in or relating to the Chemical Production of Metal-Containing Materials as Particles and other Configurations
US3563978A (en) * 1968-05-15 1971-02-16 Irving L Ochs Polyvalent metal complexes of natural polymers
US3928581A (en) * 1972-09-13 1975-12-23 Astra Laekemedel Ab Certain polymer-iron complexes for treatment of iron deficiency
SE431214B (sv) * 1977-06-02 1984-01-23 Klaus H Mosbach Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans
SE409694B (sv) 1978-01-02 1979-09-03 Odlund Bjorn Alf Ingemar Lastningsmaskin
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
HU186077B (en) * 1982-06-16 1985-05-28 Afit Iv Autojavito Vallalat Device for blocking the hand brake lever
US4731239A (en) * 1983-01-10 1988-03-15 Gordon Robert T Method for enhancing NMR imaging; and diagnostic use
WO1984002643A1 (en) * 1983-01-10 1984-07-19 Robert Thomas Gordon Method for enhancing nmr imaging; and diagnostic use
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4423158A (en) * 1983-01-27 1983-12-27 Gelinnovation Handelsaktiebolag Ion adsorbent for metals having a coordination number greater than two
DK148251C (da) 1983-02-18 1985-10-14 Dansk Gartneri Tek As Lukkemekanisme til under et tag paa raekke ophaengte gardinparter
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
CA1243602A (en) * 1983-08-25 1988-10-25 Hong-Ning Yeung Methods for enhancing the contrast in nmr imaging
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
GB8413849D0 (en) * 1984-05-31 1984-07-04 Amersham Int Plc Nmr contrast agents
JPS6162785A (ja) 1984-09-04 1986-03-31 日本プライブリコ株式会社 耐摩耗・耐火材ライニング用アンカ−
US4675173A (en) * 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
US4822594A (en) * 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images

Also Published As

Publication number Publication date
EP0184899A1 (de) 1986-06-18
DK164486B (da) 1992-07-06
JPS61155338A (ja) 1986-07-15
DK164486C (da) 1992-11-23
DK500085D0 (da) 1985-10-31
NO169525C (no) 1992-07-08
US4985233A (en) 1991-01-15
DK500085A (da) 1986-05-02
EP0184899B1 (de) 1990-04-18
NO169525B (no) 1992-03-30
NO854349L (no) 1986-05-02
JPH0678246B2 (ja) 1994-10-05

Similar Documents

Publication Publication Date Title
DE3577185D1 (de) Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
ATE231713T1 (de) Tampon für die frauenhygiene oder medizinische zwecke und verfahren zur herstellung desselben
DE3764253D1 (de) Medizinischer saugkoerper mit roentgenkontrastmittel und verfahren zu seiner herstellung.
DE69031381D1 (de) Integrierter Matrixkörper, Verfahren und Infiltrationslegierung zur Herstellung davon
TR24958A (tr) INSEKTISID YNI ETKILI N-AMINO-1,2,4,TRIAZINONLAR, BUNLARIN IMALI ICIN USULLER VE BUNLARIN ZARARLILAR LA MüCADELEDE KULLANILMASI.
DE69021283D1 (de) Ausgleich für das Nebensprechen und die Elementeverteilung eines Tonometermessfühlers.
DE3782440D1 (de) Verfahren und ausruestung zur herstellung von radioaktivmarkierten antikoerpern fuer die in-vivo-krebsdiagnose und therapie.
DE69027955D1 (de) Gleitmittel für den Heizbalg bei der Reifenherstellung
IL95394A0 (en) Amide complexes and diagnostic agents containing the same
AT362064B (de) Verfahren zur herstellung des neuen 4-spectino- mycylamins und seiner physiologisch ver- traeglichen salze
DE3763248D1 (de) Gefechtskopf und verfahren zur herstellung des gefechtskopfes.
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
AT363797B (de) Schleifkoerper und verfahren zur herstellung desselben
FI965094A (fi) 2,4,6-trijodi-5-substituoituja aminoisoftalaattiestereitä, jotka ovat hyödyllisiä varjoaineina lääketieteellisessä diagnostisessa kuvauksessa
DE69016071T2 (de) Verfahren zur Augen-Diagnostik.
DE3887811D1 (de) Faseriger Schichtstoff und Verfahren zur Herstellung desselben.
DE69011795D1 (de) Benzoxazinyl-Pyrazole und Verfahren zur Herstellung und Anwendung.
IT8984980A0 (it) Procedimento per la realizzazione di cingoli in gomma e cingolo cosi'.
FR2725023B1 (fr) Diagnostic direct d'haptenes
DE3877808D1 (de) Eisenoxidkatalysator und dessen herstellung.
AT345846B (de) Verfahren zur herstellung des neuen 4-imino- 1.3-diazabicyclo- (3.1.0)-hexan-2-on und seiner physiologisch vertraeglichen salze
ATE52032T1 (de) Paramagnetische kontrastmittel fuer die anwendung in ''in vivo'' nmr-diagnostischen methoden und die herstellung davon.
ATA363880A (de) Polierkoerper und verfahren zu seiner herstellung
DE69013726T2 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE69014169D1 (de) Polstermaterial und Verfahren für dessen Herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee